Platform · Explore

One integrated graph. Every way in

Global scientific outputs — centralized and atomized into hypotheses, research questions and results. Search, chat, visualize, or browse.

Ask AERIS

Chat grounded in the graph

Ask in plain language and get an answer grounded in the corpus — every claim traced back to the article, hypothesis, trial or patent it came from. AERIS cites its evidence and says ‘no answer’ rather than guessing.

Ask AERIS — a grounded, cited answer to a research question
Visualize the graph

See the whole corpus by meaning

See scientific knowledge as an embedding map — hypotheses, articles, patents, trials and drugs clustered by meaning, not keywords. Spot research gaps, hot topics, compare programs, and watch concepts evolve over time.

Embedding map of the corpus — hypotheses, articles, trials and drugs clustered by meaning
Search & filter

One query across every entity type

One search across global articles, hypotheses, results, patents, clinical trials, drugs, organizations, and researchers — with advanced filters and chat interrogation.

Faceted search across every entity type, with filters and sorting
Coverage

Every source, atomized and linked

AllSci aggregates the global scientific literature, patents, grants, ontologies, and other scientific outputs. The content is atomized using AllSci’s proprietary scientific AI into hypotheses, questions, results, and patent claims. All content is linked to AllSci unique identifiers for people, organizations and concepts. On this foundation, high-quality search, chat, AI workflows, and visualizations are possible.

Sources
PubMedOpenAlexUSPTONIH GrantsNSF GrantsGlobal Clinical TrialsGlobal press releases150+ More
Atoms
17M+Hypotheses17.7MResearch questions1.3MExperimental results100M+Patent claims
Integrated Profiles
100M+Researchers1M+Organizations60K+Drugs
Under the hood

We turn scientific content into logical atoms

AllSci developed a technology to generate hypotheses, questions and findings from scientific text opening up a new, better, and more natural way to engage with knowledge.

Mechanisms of anti-CD20 therapy in relapsing MS
Nakamura et al. · Nat. Neurology · 2024
Hypothesis
Question
Result
Full-text paper
HypothesisB-cell depletion lowers relapse rate ✦ grounded
QuestionDoes anti-CD20 affect disability progression? ✦ p.4
Result46% fewer relapses vs placebo ✦ Table 2
Grounded atoms
anti-CD20RRMSHypothesisQuestionResult
Connected graph
Each atom links back to the exact source span · confidence surfaced as the “AERIS Drafted” label
Tools

~4× better at grounding claims in evidence.

General models assert; AERIS cites. On the Evidence-Grounding axis of ASC-QA-Val, AERIS answers stay tied to real, retrievable sources — including the refuting ones.

frontier best · 32.1
17.8%
GPT-5.2
32.1%
Opus 4.7
69.2%
AERIS-discovery